Ava Avalos
Gaborone, Botswana
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Low-Level Viremia and Spatial Heterogeneity Among Individuals on Dolutegravir-Based Antiretroviral Therapy in Botswana: A Nationwide Study (2016-2022).
Journal: The Journal of infectious diseases
Published: April 21, 2026
The Impact of GeneXpert Cerebrospinal Fluid Testing on Tuberculous Meningitis Diagnosis in Routine Care in Botswana.
Journal: Open forum infectious diseases
Published: April 24, 2024
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in Botswana.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 19, 2023
Five years after Treat All implementation: Botswana's HIV response and future directions in the era of COVID-19.
Journal: Southern African journal of HIV medicine
Published: June 17, 2021
Etonogestrel concentrations among contraceptive implant users in Botswana using and not using dolutegravir-based antiretroviral therapy.
Journal: Contraception
Published: March 31, 2020
Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana.
Journal: AIDS (London, England)
Published: June 13, 2018
Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
Journal: The Lancet. Global health
Published: August 09, 2014
Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.
Journal: AIDS reviews
Published: December 11, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026